Form 4: MeiraGTx Holdings plc: Chief Medical Officer Reports Share Transactions
SEC Form 4 Filing
Robert K. Zeldin, Chief Medical Officer of MeiraGTx Holdings plc, reports the vesting of restricted share units and subsequent tax withholding.
Summary
- On February 21, 2025, Robert K. Zeldin, the Chief Medical Officer of MeiraGTx Holdings plc, had 15,000 restricted share units vest.
- These units converted into ordinary shares.
- 5,903 shares were withheld for payment of taxes at a price of $7.3 per share.
- Following these transactions, Zeldin directly owns 136,520 ordinary shares and 15,000 restricted share units.
Sentiment
Score: 5
Explanation: This is a routine filing reflecting standard executive compensation practices; neither particularly positive nor negative.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- Shareholders are informed about changes in insider ownership.
- The executive receives compensation in the form of shares.
Key Dates
| Date | Description |
|---|---|
| 02/21/2023 | Date of grant for the restricted share units, one-half of which vested on 02/21/2025. |
| 02/21/2025 | Date of transaction: Vesting of 15,000 restricted share units and withholding of shares for tax payment. |
| 02/25/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.